Ovarian longevity is finally entering the spotlight, and today’s conversation shows why that shift matters for every woman. In this episode, Dr. Jila sits down with Kiran Kumar, founder and CEO of Timeless Biotech, the groundbreaking company behind the first ovarian age clock and time to menopause predictor. For the first time, women can measure their ovarian aging, understand their hormonal trajectory, and use data to guide both fertility planning and long-term health.

Kiran shares how standard hormone testing has failed women for decades, why machine learning can finally close that gap, and how her team built a model that interprets FSH, AMH, estradiol and symptom patterns with accuracy we’ve never had before. You’ll hear how this technology gives clinicians a new way to track ovulation, hormone health and menopause timing, plus how it may help delay menopause by supporting ovarian function and mitochondrial health.

This episode explores the future of personalized female longevity care, from targeted interventions and retesting cycles to the cellular therapies and hormone strategies that may reshape women’s health in the years ahead. And yes, Dr. Jila’s clinic will be one of the first in the country to pilot this technology in January 2026.

For more information about Kiran Kumar and Timeless Biotech please visit the website and join the waitlist: timelessbiotech.com